Citation Impact
2 by Nobel laureates 9 from Science/Nature 62 standout
Citing Papers
Natural killer cell therapies
2024 StandoutNature
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Works of James Strauss being referenced
A phase 1, open label, dose escalation study of MGD009, a humanized B7-H3 x CD3 DART protein, in combination with MGA012, an anti-PD-1 antibody, in patients with relapsed or refractory B7-H3-expressing tumors.
2018
Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
2018
Author Peers
| Author | Oncology | Immunology | Biotechnology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| James Strauss | 375 | 332 | 36 | 208 | 65 | 748 | |
| Carmen M. Culotta | 1 | 1 | 2 | 641 | |||
| Harry Robbins | 1 | 8 | 708 | ||||
| W.H. Simmons | 392 | 37 | 15 | 270 | 17 | 594 | |
| Lingqin Huang | 8 | 2 | 1 | 31 | 345 | ||
| Carolin Kaiser | 4 | 13 | 145 |
All Works
Login with ORCID to disown or claim papers
Loading papers...